| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-12 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |